Merck (MRK) FCF Margin (2009 - 2026)

Merck has disclosed FCF Margin across 18 years of filings, most recently posting 17.97% for Q1 2026.

• In Q1 2026, FCF Margin rose 1043.0% year-over-year to 17.97%; the TTM figure through Mar 2026 stood at 21.46% (down 519.0% YoY), while the FY2025 annual figure was 19.01%, down 919.0% from the prior year.
• FCF Margin rose to 17.97% in Q1 2026, from 11.12% in the prior quarter.
• Over the last five years, FCF Margin for MRK reached as high as 51.08% in Q3 2024 and fell as low as 5.08% in Q4 2023.
• The 5-year median for FCF Margin is 18.22% (2023), against an average of 21.23%.
• Annual changes were most pronounced in 2022 — FCF Margin soared 2227 bps — and 2023, when it sank 2880 bps.
• A 5-year view of FCF Margin shows it stood at 23.72% in 2022, then tumbled by 121 bps to 5.08% in 2023, then jumped by 417 bps to 16.08% in 2024, then tumbled by 31 bps to 11.12% in 2025, then surged by 62 bps to 17.97% in 2026.
• According to Business Quant data, FCF Margin over the past three periods registered 17.97%, 11.12%, and 39.56% for Q1 2026, Q4 2025, and Q3 2025 respectively.